Institution
Université de Sherbrooke
Education•Sherbrooke, Quebec, Canada•
About: Université de Sherbrooke is a education organization based out in Sherbrooke, Quebec, Canada. It is known for research contribution in the topics: Population & Receptor. The organization has 14922 authors who have published 28783 publications receiving 792511 citations. The organization is also known as: Universite de Sherbrooke & Sherbrooke University.
Topics: Population, Receptor, Health care, Angiotensin II, Poison control
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, a new stereoelectronic theory for the cleavage of the tetrahedral intermediate in the hydrolysis of esters and amides is presented, based on the orientation of the lone pair orbitals of the hetero-atoms.
197 citations
••
TL;DR: In this paper, the relationship between microwave photons has been measured using a series of amplifiers and digital analysis, and the relationship has been shown to be robust to radiation at this wavelength.
Abstract: Detecting and counting individual microwave photons is important for processing quantum information, but it is made challenging by an absence of detectors that are sensitive enough to radiation at this wavelength Correlations between microwave photons have now been measured using a series of amplifiers and digital analysis
197 citations
••
TL;DR: La revue donne aussi des exemples de lutte biologique contre les agents phytopathogenes bacteriens and fongiques par l’utilisation d’especes d‘actinomycetes deja disponibles sur le marche ou qui le seront probablement au cours des prochaines annees.
Abstract: Les actinomycetes representent une grande proportion de la biomasse microbienne du sol et ont la capacite de produire une large variete d’antibiotiques et d’enzymes extracellulaires. Plusieurs souches d’actinomycetes s’averent capables de proteger les plantes contre des maladies. Cette revue se penche sur le potentiel des actinomycetes comme (a) source de composes agronomiques, (b) agents stimulant la croissance des plantes et (c) agents de lutte biologique. La revue donne aussi des exemples de lutte biologique contre les agents phytopathogenes bacteriens et fongiques par l’utilisation d’especes d’actinomycetes deja disponibles sur le marche ou qui le seront probablement au cours des prochaines annees.
197 citations
••
University of Toronto1, Alberta Children's Hospital2, University of Manitoba3, University of Alberta4, Mayo Clinic5, Dalhousie University6, McGill University7, Queen's University8, McMaster University9, University of Western Ontario10, Université de Sherbrooke11, Children's Hospital of Eastern Ontario12, Université de Montréal13, Janeway Children's Health and Rehabilitation Centre14, University of British Columbia15
TL;DR: This national data set provides a population-based disease incidence rate and demonstrates the protective effect of antithrombotic treatment in older children, and frequent long-term emerging deficits in neonates and in children with cardiac disorders.
197 citations
••
TL;DR: It is demonstrated that end of gestation exposure of pregnant rats to systemic microbial product (LPS) triggers placental inflammation and massive cell death, fetal mortality, and both forebrain white matter and motor behavioral alterations in the offspring, suggesting a possible protective treatment against human placental and fetal brain damage.
Abstract: The precise role of maternal bacterial infection and inflammation occurring at the end of gestation is a controversial matter. Although it is recognized as an independent risk factor for neurodevelopmental diseases such as cerebral palsy, mental deficiency, and autism, it remains unclear whether it is causal or simply associated with the diseases. In this study, we demonstrate that IL-1 plays a key role in mediating severe placental damage and neurodevelopmental anomalies in offspring. Our results show that end of gestation exposure of pregnant rats to systemic microbial product (LPS) triggers placental inflammation and massive cell death, fetal mortality, and both forebrain white matter and motor behavioral alterations in the offspring. All these effects are alleviated by the coadministration of IL-1 receptor antagonist with LPS, suggesting a possible protective treatment against human placental and fetal brain damage.
196 citations
Authors
Showing all 15051 results
Name | H-index | Papers | Citations |
---|---|---|---|
Masashi Yanagisawa | 130 | 524 | 83631 |
Joseph V. Bonventre | 126 | 596 | 61009 |
Jeffrey L. Benovic | 99 | 264 | 30041 |
Alessio Fasano | 96 | 478 | 34580 |
Graham Pawelec | 89 | 572 | 27373 |
Simon C. Robson | 88 | 552 | 29808 |
Paul B. Corkum | 88 | 576 | 37200 |
Mario Leclerc | 88 | 374 | 35961 |
Stephen M. Collins | 86 | 320 | 25646 |
Ed Harlow | 86 | 190 | 61008 |
William D. Fraser | 85 | 827 | 30155 |
Jean Cadet | 83 | 372 | 24000 |
Vincent Giguère | 82 | 227 | 27481 |
Robert Gurny | 81 | 396 | 28391 |
Jean-Michel Gaillard | 81 | 410 | 26780 |